Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Formoterol (6mcg) + Glycopyrrolate (25mcg) Rota Capsule
Therapeutic Category
Nutraceuticals, Multivitamins and Multiminerals, Asthma, Pulmonary, Respiratory
Dosage Form
Rota cap
Packaging Type
Bottle
Packaging
15ml
Price
₹450/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
In the critical care segment of respiratory health, products that offer both efficacy and convenience are a goldmine. Glycopryl FG Rota Cap, a powerful combination of Formoterol (6mcg) and Glycopyrrolate (25mcg), is a best-in-class product for the long-term management of Chronic Obstructive Pulmonary Disease (COPD) and asthma. As a PCD pharma company, we recognize the consistent, high demand for such specialized products, making this a valuable asset for any pharma distributor or wholesaler.
Formoterol: A long-acting beta-agonist (LABA) that helps relax the muscles in the airways, making breathing easier.
Glycopyrrolate: A long-acting muscarinic antagonist (LAMA) that works by reducing the production of mucus and opening up the airways.
The combined action of these two compounds provides superior and long-lasting relief from respiratory symptoms. The Rota Capsule format ensures the medication is delivered efficiently via an inhalation device, making it a highly reliable and popular choice among pulmonologists and patients alike. This market trust translates into high sales volume for our PCD pharma franchise partners.
At Cafoli Lifecare, we are committed to providing our B2B pharma partners with high-quality, profitable products. Our Glycopryl FG Rota Cap is manufactured in state-of-the-art facilities with strict quality controls. By partnering with us, you gain access to a reliable supply of this essential medication and the comprehensive support needed to succeed in the wholesale pharma market. Choose this product to build a strong and reputable business in the respiratory segment.
Common side effects can include a headache, dry mouth, muscle cramps, and dizziness. Less common but more serious side effects can include chest pain, a rapid heart rate, or blurred vision. A paradoxical bronchospasm, where the airways constrict immediately after using the medication, is a rare but life-threatening side effect. If you experience this, stop using the product and seek immediate medical attention.
This product is a combination of two bronchodilators, formoterol and glycopyrrolate. It is used for the long-term, maintenance treatment of Chronic Obstructive Pulmonary Disease (COPD), including chronic bronchitis and emphysema. Formoterol helps to relax the muscles around the airways, making it easier to breathe, while glycopyrrolate reduces secretions in the airways. It is not intended to be used as a "rescue" medication for sudden, acute breathing problems.
The "Rota Cap" is a capsule that contains powder for inhalation, and it must not be swallowed. It should be used with a device called a Rotahaler or similar inhaler, which punctures the capsule and allows the powder to be inhaled. It is crucial to follow the instructions for use provided by your doctor or pharmacist. Rinse your mouth with water after each use to reduce the risk of oral fungal infections. Do not stop using the medication without consulting your doctor, even if you feel better, as this can worsen your condition. Inform your doctor if you have a history of heart problems, glaucoma, or trouble urinating before starting this medication.
Store the capsules in their original blister pack or foil pouch at room temperature, in a dry place, away from heat and direct light. Do not open the foil pouch until you are ready to use the capsule. Keep the medication out of the reach of children.
Composition : Budesonide (0.5mg) Respule
Composition : Budesonide (100mcg) Inhaler
Composition : Budesonide (200mcg) Inhaler
Composition : Budesonide (400mcg) + Formoterol (6mcg) Rota Caps
Composition : Budesonide (0.5mg) + Formoterol (20mcg) Respule
Composition : Formoterol (20mcg) + Budesonide (0.5mg) Respule
Composition : Levosalbutamol (1.25mg) + Budesonide (0.5mg) Respule
Composition : Glycopyrronium (25mcg) + Formoterol (12mcg)+ Budesonide (400 mcg) Rota Capsule
Composition : Formoterol 6mcg + Budesonide 400mcg Rota Capsule
Composition : Formoterol (6mcg) + Budesonide (400mcg) Inhaler
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
This combination has strong demand in the respiratory and pulmonary care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on asthma, COPD, and chronic lung disease portfolios.
Medical distributors and agencies can benefit from consistent demand for management of Chronic Obstructive Pulmonary Disease (COPD), asthma, and long-term bronchospasm control. Glycopyrrolate acts as a long-acting muscarinic antagonist (LAMA) that relaxes airway muscles Formoterol is a long-acting beta-agonist (LABA) that improves airflow and reduces breathing difficulty This dual bronchodilator combination strengthens a reliable respiratory-care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Glycopyrrolate + Formoterol Rota Cap with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from pulmonologist prescriptions, chronic COPD patient demand, long-term daily usage, hospital and clinic supply, reliable supply chain support, and good margins in respiratory medicines.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to discuss pricing, monopoly territory rights, and distribution opportunities.